Third Party Cyber Insurance Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Accenture, Aon, IBM, CyberArk, Oracle, F5, FireEye, Forcepoint, Fortinet, and AWS
April 19, 2024 08:58 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Third Party Cyber Insurance Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
April 19, 2024 07:00 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA...
Global Gamification Market Size To Exceed USD 96.2 Billion By 2033 | CAGR of 23.56%
April 15, 2024 14:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 15, 2024 (GLOBE NEWSWIRE) -- The Global Gamification Market Size is to Grow from USD 11.6 Billion in 2023 to USD 96.2 Billion by 2033, at a Compound Annual Growth...
The Joint Commission Enterprise Announces Four Appointments to Executive Leadership Team
April 11, 2024 12:59 ET
|
The Joint Commission
OAKBROOK TERRACE, Illinois, April 11, 2024 (GLOBE NEWSWIRE) -- (OAKBROOK TERRACE, Illinois, April 11, 2024) – Building on a strong team of healthcare leaders to support its strategic transformation...
Oculis Announces Completion of Oversubscribed $59 Million Registered Direct Offering and Subsequent Listing on Nasdaq Iceland Main Market
April 11, 2024 08:55 ET
|
Oculis Holding AG
$59 million financing includes participation from new Icelandic institutional and existing investors; Extends cash runway until 2H 2026 The Central Bank of Iceland, Financial Supervision has approved...
Oculis Strengthens its Executive Leadership Team with the Appointment of Snehal Shah, Pharm.D. as President of Research & Development
April 10, 2024 06:30 ET
|
Oculis Holding AG
Following significant strides made in advancing its late-stage pipeline with dual positive readouts in 2023 and a few more anticipated this year, Oculis further expands its executive leadership team...
Positive Results from Phase 3 OPTIMIZE-1 Trial of Once Daily OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgery Presented at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
April 08, 2024 06:30 ET
|
Oculis Holding AG
OCS-01 positive results in the first Phase 3 OPTIMIZE-1 trial were presented at the American Society of Cataract and Refractive Surgery (ASCRS) while topline readout from the second Phase 3 OPTIMIZE-2...
Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery
April 04, 2024 08:00 ET
|
American Oncology Network
MACON, Ga., April 04, 2024 (GLOBE NEWSWIRE) -- Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s...
Oculis to Participate at Upcoming April Investor Conferences
April 04, 2024 06:30 ET
|
Oculis Holding AG
ZUG, Switzerland and BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care,...
American Oncology Network Expands to Hawaii, Welcomes New Practice to Network
April 03, 2024 08:00 ET
|
American Oncology Network
HONOLULU, April 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing community oncology networks, is pleased to announce its expansion...